uromitexan
baxter healthcare pty ltd - mesna -
vetace 2.5mg tablets for dogs and cats
zoetis australia pty ltd - benazepril hydrochloride - oral tablet - benazepril hydrochloride ungrouped active 2.5 mg/tb - cardiovascular system - cat | dog | bitch | castrate | cat - queen | cat - tom | kitten | puppy - chronic renal insufficiency | congestive heart failure | hypertrophic cardiomyopathy | dilated cardiomyopathy | mitral and/or tricuspid regur | valvular insufficiency
gamunex - c
padagis israel agencies ltd, israel - immunoglobulins, normal human - solution for infusion - immunoglobulins, normal human 0.1 g/ml - immunoglobulins, normal human, for intravascular adm. - immunoglobulins, normal human, for intravascular adm. - gamunex is indicated as replacement therapy of primary immunodeficiency (pi) states in which severe impaiment of antibody forming capacity has been shown, such as congential agammaglobulinemia, common variable immunodeficiency, x-limked immunodeficiency with hyper igm, wiskott- aldrich syndrom, and severed combined immunodeficiencies. gamunex is also indicated in idiopathic thrombocytopenia purpura (itp) to raise platelet counts to prevent bleeding or to allow a patient with itp to undergo surgery.treatment of chronic inflammatory demyelinating polyneuropathy (cidp).
nootropil (piracetam) 800 mg film-coated tablets
ucb pharma sa 60 allee de la recherche, b-1070 brussels, belgium - piracetam - film-coated tablet - piracetam 800 mg - psychoanaleptics
avandamet
smithkline beecham plc - rosiglitazone, metformin hydrochloride - diabetes mellitus, type 2 - drugs used in diabetes - avandamet is indicated in the treatment of type 2 diabetes mellitus patients, particularly overweight patients:who are unable to achieve sufficient glycaemic control at their maximally tolerated dose of oral metformin alone.in triple oral therapy with sulphonylurea in patients with insufficient glycaemic control despite dual oral therapy with their maximally tolerated dose of metformin and a sulphonylurea (see section 4.4).
indapamide 2.5mg tablets
de pharmaceuticals - indapamide hemihydrate - oral tablet - 2.5mg
uromitexan mesna 600mg tablet blister pack
baxter healthcare pty ltd - mesna, quantity: 600 mg - tablet, film coated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; calcium hydrogen phosphate dihydrate; maize starch; povidone; magnesium stearate; hypromellose; macrogol 6000; titanium dioxide; simethicone - for the reduction and prevention of urinary tract toxicity (haemorrhagic cystitis) of oxazaphosphorines (see adverse effects section of the cyclophosphamide and ifosfamide product information)
uromitexan mesna 400mg tablet blister pack
baxter healthcare pty ltd - mesna, quantity: 400 mg - tablet, film coated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; calcium hydrogen phosphate dihydrate; maize starch; povidone; magnesium stearate; hypromellose; macrogol 6000; titanium dioxide; simethicone - for the reduction and prevention of urinary tract toxicity (haemorrhagic cystitis) of oxazaphosphorines (see adverse effects section of the cyclophosphamide and ifosfamide product information)
ceretam 800mg film-coated tablet
av manufacturing sdn.bhd - piracetam -
ceretam oral solution 20% wv
av manufacturing sdn.bhd - piracetam -